| Literature DB >> 34209070 |
Yan Xu1, Yiqun Li1, Mingyang Xue1, Tao Yang2, Xiaowen Luo1, Yuding Fan1, Yan Meng1, Wenzhi Liu1, Ge Lin1, Bo Li3, Lingbing Zeng1, Yong Zhou1.
Abstract
The present study aimed to evaluate the effect of the dietary supplementation of Saccharomyces cerevisiae YFI-SC2 on the growth performance, intestinal morphology, immune parameters, intestinal microbiota, and disease resistance of crayfish (Procambarus clarkia). Crayfish were randomly assigned to six different boxes and two different groups in triplicate. The control group received a basal diet and the treatment group received a diet containing S. cerevisiae at 107 CFU/g. After feeding for 28 days, crayfish of the treatment group exhibited a significantly better weight gain ratio (WGR) and a specific growth rate (SGR) (p < 0.05) than crayfish of the control group. Compared to the treatment group, the control group intestines showed an oedema connective tissue layer and a weak muscle layer. For immune-related genes, Crustin2 expression was similar between the groups, whereas Lysozyme and prophenoloxidase from treatment group expression levels were upregulated significantly (p < 0.05) after 14 and 28 days of feeding. Prophenoloxidase showed the highest expression, with 10.5- and 8.2-fold higher expression than in the control group at 14 and 28 days, respectively. The intestinal microbiota community structure was markedly different between the two groups. After 14 and 28 days of feeding, the relative abundance of Cetobacterium and Lactobacillus increased, whereas Citrobacter and Bacteroides decreased in the treatment group compared with that of the control group. The challenge test showed that crayfish of the treatment group had a significantly enhanced resistance against Citrobacter freundii (p < 0.05). Our results suggest that a S. cerevisiae-containing diet positively influenced the health status, immune parameters, intestinal microbiota composition, and disease resistance of crayfish.Entities:
Keywords: Saccharomyces cerevisiae; crayfish; growth; immune; intestinal microbiota; intestinal morphology
Year: 2021 PMID: 34209070 PMCID: PMC8300296 DOI: 10.3390/ani11071963
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
List of primers used in this study.
| Genes | Primer Sequence (5′-3′) | GenBank Number |
|---|---|---|
|
| ||
| 18S-F | TGGTGCATGGCCGTTCTTA | MT829236.1 |
| 18S-R | AATTGCTGGAGATCCGTCGAC | |
| Crustin2-F | GGGAAGAAAAGCACAATGGT | GQ301202.1 [ |
| Crustin2-R | GGTATGGAGGTCGAGACAGG | |
| Prophenoloxidase-F | AGGTGGATCAGCCAGCAGT | EF595973.1 [ |
| Prophenoloxidase-R | CGTAGTCAGCAGCGGAGGT | |
| Lysozyme-F | GATTGCTTAGGGTGCTTGTGCGA | GQ301200.1 [ |
| Lysozyme-R | GGGTTTGCCAGCTTCATTCCAGT | |
| Toll-like receptor-F | GACTTGTCCAAAAACGATATACG | KP259728.1 [ |
| Toll-like receptor-R | TGCGTTACAGTAGTGAGCGAAT | |
|
| ||
| 338F | ACTCCTACGGGAGGCAGCA | |
| 806R | GGACTACHVGGGTWTCTAAT | |
Growth performance of crawfish fed with different experimental diets for 14 and 28 days.
| Parameters | Dietary Treatments | |||
|---|---|---|---|---|
| CG14d | TG14d | CG28d | TG28d | |
| Initial weight (g) | 13.72 ± 0.18 | 13.69 ± 0.21 | 13.72 ± 0.18 | 13.69 ± 0.21 |
| Weight at sampling (g) | 15.13 ± 0.32 | 15.45 ± 0.39 | 16.67 ± 0.38 a | 17.43 ± 0.37 b |
| WGR (%) | 10.13 ± 0.43 | 12.86 ± 0.57 | 21.61 ± 1.03 a | 27.09 ± 1.87 b |
| SGR (%/d) | 0.69 ± 0.04 | 0.81 ± 0.13 | 0.72 ± 0.05 a | 0.86 ± 0.07 b |
| Survival rate (%) | 95.83 ± 1.44 | 96.25 ± 1.25 | 92.08 ± 0.72 | 93.75 ± 1.25 |
Note: CG14d and CG28d represents the control group after 14 days and 28 days of feeding. TG14d and TG28d represents the treatment group (S. cerevisiae at 107 CFU/g diet) after 14 days and 28 days of feeding. Each value represents mean ± SD (n = 3), and bars with different letters indicate a significant different by LSD test for each time point (p < 0.05).
Figure 1Intestinal morphology analysis of crayfish fed with different experimental diets for 14 days and 28 days. (A) control group after 14 days of feeding ((A): 100×, (A’): 50×); (B) control group after 28 days of feeding ((B): 100×, (B’): 50×); (C) treatment group (S. cerevisiae at 107 CFU/g diet) after 14 days of feeding ((C): 100×, (C’): 50×); (D) treatment group (S. cerevisiae at 107 CFU/g diet) after 28 days of feeding ((D): 100×, (D’): 50×). CL: chitinous layer; EL: epithelial layer; CT: connective tissue layer; ML: muscle layer; A: adventitia.
Figure 2Relative mRNA expression of immunity-related genes in crayfish hepatopancreas tissue after the feeding trial. (A): Crustin2 gene expression; (B): toll gene expression; (C): prophenoloxidase gene expression; (D): lysozyme gene expression. Each value represents mean ± SD (n = 3), and bars with different letters indicate significant differences by the LSD test for each time point (p < 0.05). CG, control group; TG, treatment group (S. cerevisiae at 107 CFU/g diet).
OTUs classification information and alpha diversity index of microbial community in the intestines of crayfish.
| Sample ID | OTUs | Chao 1 | Shannon |
|---|---|---|---|
| CG14d | 170 ± 28 a | 207.08 ± 15.89 a | 2.33 ± 0.27 a |
| TG14d | 241 ± 31 b | 258.97 ± 28.48 b | 2.97 ± 0.32 b |
| CG28d | 171 ± 17 a | 201.04 ± 9.75 a | 2.42 ± 0.15 a |
| TG28d | 228 ± 23 ab | 250.16 ± 16.48 b | 2.85 ± 0.39 ab |
Note: each value represents mean ± SD (n = 3). Different letters are significantly (p < 0.05) different by the LSD test. CG14d, control group after 14 days of feeding; CG28d, control group after 28 days of feeding; TG14d, treatment group (S. cerevisiae at 107 CFU/g diet) after 14 days of feeding; TG28d, treatment group (S. cerevisiae at 107 CFU/g diet) after 28 days of feeding; OUT, operational taxonomic unit.
Figure 3Relative abundance of the intestinal microbiota of crayfish at the phylum (A) and genus (B) levels. CG14d, control group after 14 days of feeding; CG28d, control group after 28 days of feeding; TG14d, treatment group (S. cerevisiae at 107 CFU/g diet) after 14 days of feeding; TG28d, treatment group (S. cerevisiae at 107 CFU/g diet) after 28 days of feeding.
Figure 4Principal coordinate analysis (PCoA) based on unweighted Unifrac distances. CG14d, control group after 14 days of feeding; CG28d, control group after 28 days of feeding; TG14d, treatment group (S. cerevisiae at 107 CFU/g diet) after 14 days of feeding; TG28d, treatment group (S. cerevisiae at 107 CFU/g diet) after 28 days of feeding.
Figure 5Cumulative survival following a 10-day C. freundii challenge in crayfish. Each value represents the mean ± SD (n = 3). Different letters were significantly (p < 0.05) different by LSD test. CG14d, control group after 14 days of feeding; CG28d, control group after 28 days of feeding; TG14d, treatment group (S. cerevisiae at 107 CFU/g diet) after 14 days of feeding; TG28d, treatment group (S. cerevisiae at 107 CFU/g diet) after 28 days of feeding.